Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 19/20 | 0.62 |
| ▸ | GABRG2 | P18507 | 19/20 | 0.62 |
| ▸ | GABRB3 | P28472 | 19/20 | 0.62 |
| ▸ | GABRA3 | P34903 | 19/20 | 0.62 |
| ▸ | GABRA5 | P31644 | 17/20 | 0.62 |
| ▸ | GABRA2 | P47869 | 17/20 | 0.62 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.62 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.62 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7479860 | 0.79 | GABRA1 (0.83) | GABRA1GABRG2GABRB3GABRA3GABRA5 | |
| SCHEMBL2461190 | 0.77 | GABRA1 (1.00) | GABRA1GABRG2GABRB3GABRA3GABRA5 | |
| SCHEMBL7475561 | 0.77 | GABRA1 (0.75) | GABRA1GABRG2GABRB3GABRA3GABRA5 | |
| SCHEMBL7476419 | 0.76 | GABRA1 (0.66) | GABRA1GABRG2GABRB3GABRA3GABRA5 | |
| SCHEMBL7473426 | 0.75 | GABRG2 (1.00) | GABRA1GABRG2GABRB3GABRA3GABRA5 | |
| SCHEMBL7480257 | 0.74 | GABRA1 (0.72) | GABRA1GABRG2GABRB3GABRA3GABRA5 | |
| SCHEMBL7478334 | 0.74 | GABRA1 (0.80) | GABRA1GABRG2GABRB3GABRA3GABRA5 | |
| SCHEMBL1257594 | 0.74 | GABRA1 (1.00) | GABRA1GABRG2GABRB3GABRA3GABRA5 | |
| SCHEMBL29550288 | 0.74 | GABRA1 (1.00) | GABRA1GABRG2GABRB3GABRA3GABRA5 | |
| SCHEMBL7473350 | 0.74 | GABRA1 (0.74) | GABRA1GABRG2GABRB3GABRA3GABRA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6310203-B1 | Precursor compounds to substituted 1,2,4-triazolo[3,4,-a]phathalazine GABA alpha 5 ligands | MERCK SHARPE & DOHME LIMITED (GB) | 2001-10-30 | — | — | US | disclosed |
| US-6200975-B1 | FOR COGNITION ENHANCEMENT THERAPY | MERCK SHARP & DOHME LIMITED (GB) | 2001-03-13 | — | — | US | disclosed |